Positive association of common variants in CD36 with















































Age-related macular degeneration (AMD) is a leading 
cause of legal blindness among older individuals of 
industrialized countries  [1]. The advanced stage of 
AMD is classified into atrophic (dry) or neovascular 















































































polymorphisms  (SNPs)  across  CD36  for  their  association  with  the  disease  in  a  Japanese  population  comprising  109










rophy of the retinal pigment epithelium (RPE) and 
photoreceptors of the macula, whereas the neovascular 
type is characterized by choroidal neovascularization 
(CNV) and its sequela. Although the growing 
prevalence of AMD could be attributed to an aging 
population, the precise etiology remains elusive. Many 
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in the pathogenesis of AMD. To date, genetic variants 
in the complement factor H (CFH) gene on 
chromosome 1q32 [2-7] and in two tightly linked 
genes—age-related maculopathy susceptibility 2 
(ARMS2), also known as LOC387715, and high-
temperature requirement factor A1 (HTRA1) on 10q26 
[8-13]
  — have demonstrated the strongest replicable 
associations with AMD across multiple ethnic groups. 
Variants in two adjacent genes complement factor B, 
complement component 2 on 6p21 [14, 15], and 
complement component 3 gene on 19p13 [16-18] have 
also demonstrated replicable associations with AMD 
among Caucasians. 
 
CD36 is involved in diverse physiological and 
pathological processes, including scavenger receptor 
functions (e.g., uptake of oxidized lipids and advanced 
glycation end products), transforming growth factor-β 
activation, lipid metabolism, angiogenesis, athero-
genesis, and inflammation [19-21]. These wide variety 
functions are a result of the diverse ligands with which 
CD36 can interact [19-21].  In particular, CD36 is 
known as a critical receptor for thrombospondin-1 
(TSP-1). The CD36/TSP-1 signal is essential for the 
inhibition of neovascularization, thereby maintaining 
the quiescence of the normal vasculature [19, 20]. A 
recent in vivo study demonstrated that down-regulation 
of CD36 in capillary sprout endothelial cells facilitated 
angiogenesis and results indicated that the cells were 
becoming insensitive to antiangiogenic TSP-1 signaling 
[22]. In the eye, CD36 was reported to play a major role 
in the inhibition and regression of corneal 
neovascularization [23]. CD36 also seems to play an 
important role in maintaining chorioretinal homeostasis. 
Notably, rats carrying a specific genetic variant of 
CD36 have been found to be more susceptible to light-
induced retinal damage [24], and are more likely to 
develop age-related retinal degeneration and chorio-
capillary rarefaction [25]. 
 
Oxidative stress is widely recognized as an important 
component in the pathogenesis of AMD [26, 27]. The 
susceptibility of RPE cells to oxidative stress 
progressively increases with age, and the cumulative 
oxidative damage causes RPE dysfunction and 
apoptosis, either directly or through inflammatory 
processes [26, 27]. CD36 could be regarded as a link 
between oxidative stress and oxidative RPE damage, 
given that CD36 is involved in the uptake of oxidized 
lipids by RPE cells [28], which can initiate many of the 
cellular events relevant to AMD pathogenesis. A recent 
in vitro study reported that the uptake of oxidized low-
density lipoprotein (oxLDL) induces the expression of 
several genes related to oxidative stress, inflammation, 
and apoptosis for RPE cells [29]. An immuno-
histochemical study reported the presence of oxLDL in 
surgically excised CNV membranes [30]. Furthermore, 
CD36 is involved in the phagocytosis of photoreceptor 
outer segments (OSs), where light-induced oxidation of 
retinal OS phospholipids enhances CD36-mediated 
phagocytosis [31]. In vitro evidence indicates that an 
exposure of RPE cells to oxLDL compromises the 
phagocytic ability of RPE cells [32]. This dysfunction 
can give rise to the accumulation of lipofuscin in RPE 
cells, which further precipitates oxidative conditions 
and RPE damage [26, 27]. 
 
Taken together, CD36 can have specific and important 
functions in the pathological events involved in AMD 
and neovascularization. With the hypothesis that genetic 
variants in CD36 could be associated with neovascular 
AMD, we examined the presence of an association of 






The demographic details of the study population are 
listed in Table 1. Marker information, allelic fre-
quencies, and summary statistics for all evaluated single 
nucleotide polymorphisms (SNPs) are shown in Table 
2. Five of the 19 SNPs showed nominally significant 
associations with neovascular AMD (P < 0.05), of 
which two (rs3173798 and rs3211883) withstood 
Bonferroni correction for multiple testing (Bonferroni-
corrected P = 0.0189 and 0.00397, respectively; Table 
2). Applying a permutation procedure for multiple test 
correction also yielded significant P values only for the 
two SNPs, rs3173798 and rs3211883 (corrected 
empirical  P = 0.0155 and 0.0043, respectively). The 
minor allele C at rs3173798 was associated with 
protection against neovascular AMD, with a frequency 
of 0.307 in cases and 0.445 in controls (nominal P = 
9.96 × 10
−4; empirical pointwise P = 0.0018; per allele 
odds ratio = 0.55 [95% confidence interval: 0.39-0.79]). 
The minor allele A at rs3211883 was also protective 
against the disease, with a frequency of 0.248 in cases 
and 0.398 in controls (nominal P = 2.09 × 10
−4; 
empirical pointwise P = 5.0 × 10
−4; per allele odds ratio 
= 0.50 [95% confidence interval: 0.34-0.72]). Inclusion 
of age and sex as covariates in logistic regression 
models did not substantially change the significance of 
the observed associations (rs3173798, age- and sex-
adjusted odds ratio = 0.59 [95% confidence interval = 
0.41-0.84], P = 3.10 × 10
−3, additive model; rs3211883, 
age- and sex-adjusted odds ratio = 0.5 [95% confidence 
interval = 0.36 - 0.77],  P =  7.0 × 10
−4,  additive  the 
   

































































































model). The two SNPs, rs3173798 and rs3211883, were 
highly correlated with each other (r
2 = 0.80); thus, their 
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redundant). When either SNP rs3173798 or rs3211883 
was fitted in the logistic regression, all other SNPs 
showing nominally significant association (rs10499862, 


















The pairwise linkage disequilibrium (LD) structure was 
constructed with all SNPs evaluated (Figure 1a). Using 
the criteria described by Gabriel et al. [33], three 
haplotype blocks were defined (Figure 1a). Haplotype 
analyses from all blocks revealed that the association 
with neovascular AMD was restricted to block 1 and 2, 
as demonstrated by the significant omnibus results 
(omnibus P = 0.00482 and 0.00181, respectively; Table 
3). As shown in Table 3, one haplotype in block 1 and 
two haplotypes in block 2 were found to be significantly 
associated with the disease after correction for multiple 
testing (permutation P < 0.05). A risk haplotype (under-
lined in Table 3) showed a solid spine of LD across 
blocks 1 and 2, with haplotype frequencies of 0.404 in 
affected individuals and 0.288 in controls (P = 0.0043; 
odds ratio = 1.67 [95% confidence interval = 1.17-
2.38]; Figure 1b). This haplotype was completely 
described by the allele T at rs3173800. The protective 
allele A at rs3211883 was split into two different 
haplotypes, one of which showed statistical significance 
for protection against neovascular AMD (P = 0.0067; 
odds ratio = 0.48 [95% confidence interval = 0.28-
0.83]; Table 3). 
 
Assessment of population stratification 
 
Hidden population stratification between cases and 
controls can generate a false positive association. The 
population stratification was examined by 
STRUCTURE [34]  using 26 unlinked genome-wide 
SNPs. We found no evidence of significant stratification  
in our study cohort [Pr (K = 1 > 0.99)], indicating that 
population stratification did not account for association 




We tested biological candidate gene CD36 and found 
that common variants in this gene are associated with 
neovascular AMD in a Japanese population. We 
confirmed the lack of population stratification between 
case and control subjects in the present study. Our 
results implicate CD36 as a previously unknown genetic 
risk factor for neovascular AMD. 
  Neovascular 
AMD 
Controls 
Number of subjects  109  182 
Gender (male/female)  87/22  110/72 
Mean age ± SD (years)  76 ± 7.3  72 ± 5.8 




We identified two protective variants satisfying 
stringent statistical thresholds for significance; 
rs3211883 was the most significant SNP (nominal 
allelic  P = 2.09 × 10
−4), followed by rs3173798 
(nominal allelic P = 9.96 × 10
−4). The two SNPs were 
highly correlated with each other (r
2 = 0.80); therefore, 
their effects could not be separated statistically in our 
dataset. The biological basis of the associations is 
currently unknown because the two SNPs do not reside 
in the coding sequence of CD36. Using the FASTSNP 
program [35],  we predicted binding of the CDX1 intro-
nic enhancer to the sequence containing rs3211883 and 
rs3173798 to be located in a potential splice site. Thus, 
these two SNPs could have non-coding effects on gene 
function; however, exhaustive resequencing of the locus 
is required to search potentially undiscovered and more 
important causative variants. 
 
CD36 is located on chromosome 7q11.2, a region that 
has not been previously implicated in AMD. We 
examined SNPs across a 366 kb region harboring CD36 
and two flanking genes  (GNAT3 and SEMA3C)  in  an 
available database, the NEI/NCBI dbGAP database 
(http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study. 
cgi?id=phs000001). This database provides results of a 
genome-wide association (GWA) analysis between 395 
individuals with AMD and 198 controls from the 
National Eye Institute Age-Related Eye Disease Study 
(AREDS). This analysis did not include the two most 
significant SNPs (rs3173798 and rs3211883) or any of 
the three SNPs (rs10499862, rs3173800, and 
rs17154232) that showed nominally significant 
associations in our study. The GWA study looked at 
five  CD36 SNPs (rs1194182, rs3211822, rs3211885, 
rs1405747, and rs7755) and found no significant 
association (all nominal P > 0.05). Of the five GWA 
SNPs, rs7755 was also typed in our study and all of the 
remaining GWA SNPs were captured by our tag SNPs;  
rs1194182 was highly correlated with rs3211849 (r
2 = 
0.95) and rs3211822, rs3211885, and rs1405747 were a  
 
   


































2 =1) for rs3211816, rs3211870, and 
rs7755, respectively, according to the HapMap JPT 
data. Consistent with the GWA data from AREDS, none 
of the four proxy SNPs (rs3211849, rs3211816, 
rs3211870, and rs7755) showed a significant 
association with neovascular AMD in our study (all 
nominal P > 0.05), indicating that the GWA study in the 
AREDS cohort was unable to capture the genetic effects 






































      Minor Allele Frequency  Association Results 
SNP Location 
Minor 
Allele Cases  Controls 















rs12531609  Intron 1  T  0.165  0.223  0.0945 (0.138)  0.69 (0.45-1.07)  0.608  1 
rs3211816  Intron 3  A  0.509  0.475  0.428 (0.451)  1.15 (0.82-1.60)  0.995  1 
rs10499862  Intron 3  C  0.106  0.187  0.00895 (0.0126)  0.51 (0.31-0.85)  0.113  0.17 
rs3211849  Intron 3  A  0.289  0.269  0.606 (0.628)  1.10 (0.76-1.60)  1  1 
rs3211851  Intron 3  C  0.202  0.253  0.160 (0.20)  0.75 (0.50-1.12)  0.799  1 
rs1054516  Intron 3  C  0.395  0.459  0.130 (0.136)  0.77 (0.55-1.08)  0.726  1 
rs3173798  Intron 3  C  0.307  0.445  9.96 × 10
−4 (0.0018)  0.55 (0.39-0.79)  0.0155  0.0189 
rs3211870  Intron 4  C  0.454  0.511  0.184 (0.181)  0.80 (0.57-1.12)  0.839  1 
rs1358337  Intron 4  G  0.349  0.319  0.457 (0.454)  1.14 (0.80-1.63)  0.996  1 
rs3211883  Intron 4  A  0.248  0.398  2.09 × 10
−4 (5.0 × 10
−4) 0.50  (0.34-0.72)  0.0043  0.00397 
rs3173800  Intron 4  T  0.404  0.289  0.00427 (0.00570)  1.67 (1.17-2.38)  0.0538  0.0812 
rs1924  Intron 5  A  0.161  0.220  0.0824 (0.0877)  0.68 (0.44-1.05)  0.570   1 
rs17154232  Intron 6  C  0.087  0.151  0.0250 (0.0411)  0.54 (0.31-0.93)  0.256  0.475 
rs17154233  Intron 6  C  0.266  0.203  0.0801 (0.0776)  1.42 (0.96-2.11)  0.555  1 
rs3211908  Intron 7  T  0.142  0.146  0.91 (1)  0.97 (0.60-1.57)  1  1 
rs17154258  Intron 8  G  0.142  0.184  0.191 (0.218)  0.73 (0.46-1.17)  0.860  1 
rs1527483  Intron 11  A  0.179  0.176  0.925 (1)  1.02 (0.66-1.58)  1  1 
rs3211958  Intron 14  G  0.367  0.396  s0.492 (0.531)  0.89 (0.63-1.25)  0.998  1 
















Cumulative oxidative stress is an important component 
of AMD pathogenesis because of its contribution to 
RPE damage and subsequent pathology such as the 
activation of inflammatory responses in the Bruch 
membrane and choroids  [26, 27]. It is possible that 
altered CD36 biologic behavior, which is defined by 
common variations in this gene, could be a contributing  
factor for this pathogenic sequence of events given its 
ability to scavenge oxidized lipids [28, 29]  and  phago- 
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stress [31]. The ability of CD36 to mediate the 
antiangiogenic activity of TSP-1 would also predict a 
proangiogenic consequence of CD36 dysfunction [19, 
20]. Further support for the involvement of CD36 in 
AMD pathogenesis can be found in studies involving 
CD36-deficient animals. Rats carrying a specific 
genetic variant of CD36 have been shown to be more 
susceptible to light-induced retinal damage [24], and are 
more likely to develop an age-related retinal 
degeneration and choriocapillary rarefaction [25]. This 
observation could serve as a link between the genetic 











































that a markedly decreased choroidal circulation 
precedes the appearance of CNV in neovascular AMD 
[36]. 
 
In conclusion, we report a novel association between 
common variants in CD36 and neovascular AMD in a 
Japanese population. Although the underlying causative 
biological perturbation related to these variants is not 
yet clear, this study supports the candidacy of CD36 as 
a novel susceptibility gene for neovascular AMD. 
Replication of our results in other populations will 
provide further convincing evidence for the association 





























 Frequency       
 Cases Controls P-value†  OR (95% CI)  Omnibus P-
value‡ 
Block 1  0.404  0.288  0.0043  1.67 (1.17-2.38) 
0.00482 
 0.289  0.269  0.606 1.10  (0.76-1.60) 
 0.202  0.253  0.160 0.75  (0.50-1.12) 
 0.106  0.187  0.0089  0.51  (0.31-0.85) 
Block 2           
 0.404  0.288  0.0043  1.67  (1.17-2.38) 
0.00181 
 0.344  0.313  0.443 1.15  (0.80-1.64) 
 0.156  0.219  0.06 0.65  (0.42-1.02) 
 0.092  0.173  0.0067  0.48  (0.28-0.83) 
Block 3           
 0.491  0.420  0.0978  1.33  (0.95-1.86) 
0.328 
 0.188  0.220  0.362 0.82  (0.54-1.25) 
 0.179  0.173  0.858 1.04  (0.67-1.62) 
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Study Participants.  This study was approved by the 
Institutional Review Board at Kobe University Graduate 
School of Medicine and was conducted in accordance 
with the Declaration of Helsinki. Written informed 
consent was obtained from all subjects. All cases and 
controls included in this study were Japanese 
individuals recruited from the Department of 
Ophthalmology at Kobe University Hospital in Kobe, 
Japan. 
 
All patients with neovascular AMD received 
ophthalmic examinations, including visual acuity 
measurement, slit-lamp biomicroscopy of the fundi, 
color fundus photographs, optical coherence tomo-
graphy, fluorescein angiography, and indocyanine green 
angiography. All of our study subjects with neovascular 
AMD had CNV and associated manifestations such as 
nondrusenoid pigment epithelial detachment, serous or 
hemorrhagic retinal detachments, subretinal or sub-RPE 
hemorrhages, and fibrosis, and thus, were categorized as 
having clinical age-related maculopathy staging system 
(CARMS) stage 5 [37]. Patients with polypoidal 
choroidal vasculopathy and secondary choroidal 
neovascular diseases such as degenerative myopia, 
ocular trauma, angioid streaks, idiopathic CNV, and 
presumed ocular histoplasmosis were excluded from our 
study. The control subjects were 56 years of age or 
older and were defined as individuals without macular 
degeneration and macular changes such as drusen or 
pigment abnormalities. Thus, controls were categorized 
as having CARMS stage 1 [37]  on the basis of 
comprehensive ophthalmic examinations. 
 
SNP selection. To comprehensively yet efficiently 
screen  CD36 sequences for genetic variations in a 
Japanese population, we ran Tagger tool [38] from 
HapMap Project database for the Japanese in Tokyo 
(JPT) population [39] (minor allele frequency cutoff 
was set at 0.1; r
2 cutoff was set at 0.8; and the Tagger 
Pairwise mode was used). Nineteen tag SNPs across a 
74.5 kb region encompassing CD36 were selected for 
genotyping. Based on the HapMap JPT data, these 19 
SNPs captured 121 of 123 SNPs in CD36 exhibiting a 
minor allele frequency greater than 10% with a mean r
2 
value of 0.97. Thus, our set of 19 SNPs is highly 
representative of the common genetic variation in CD36 
because it acts as a proxy marker for other untyped 
SNPs in this region. 
 
Genotyping. Genomic DNA was extracted from the 
peripheral blood using a standard methodology. 
Genotyping was performed using TaqMan
® SNP 
Genotyping Assays (Applied Biosystems, Foster City, 
CA) on a StepOnePlus™ Real-Time PCR System 
(Applied Biosystems) in accordance with the supplier’s 
recommendations. 
 
Statistical Analysis. Each marker was tested for 
association using a software package, PLINK v1.00 
(http://pngu.mgh.harvard.edu/purcell/plink/) [40]. In ad-
dition to obtaining nominal P-values, empirical P-
values were generated by 10,000 permutation tests 
using Max (T) permutation procedure implemented in 
PLINK [40]. In this procedure, two sets of empirical 
significance values were calculated: pointwise estimates 
of an individual SNP’s significance (empirical 
pointwise P-values) and corrected values for multiple 
testing (corrected empirical P-values). We also applied 
a Bonferroni correction [41], which is the most 
conservative correction for multiple testing, where 
nominal P-values were multiplied by 19 (the number of 
SNPs tested for association). To adjust for age and sex 
differences between the case and control subjects, 
logistic regression analyses were performed using 
SNPStats (http://bioinfo.iconcologia.net/SNPstats), with 
age and sex controlled as covariates. Age and sex were 
included in this model as a continuous covariate 
measured in years and a categorical covariate, 
respectively. Deviations from Hardy-Weinberg 
equilibrium were tested using the chi-square test (1 
degree of freedom), and all of the 19 SNPs passed the 
Hardy-Weinberg equilibrium tests in both the case and 
control subjects (P > 0.001) [41]. To dissect multiple 
association signals due to LD patterns, we conducted 
conditional logistic regression analyses  using the 
logistic and condition options in PLINK. The FASTSNP 
program  (http://fastsnp.ibms.sinica.edu.tw/pages/input_ 
CandidateGeneSearch.jsp) was used to investigate the 
potential function of SNP [35]. 
 
A software package, Haploview, was used for assessing 
LD patterns and haplotype association statistics [42]. 
Haplotype blocks were determined using the algorithm 
of Gabriel et al [33]. To correct for multiple testing in 
the haplotype analysis, 10,000 permutations were run 
using Haploview. Odds ratios and 95% confidence 
intervals for haplotype-specific risks were calculated 
using VassarStats (http://faculty.vassar.edu/lowry/Vassar 
Stats.html). An omnibus (or global) test of the 
haplotype association was conducted with PLINK. 
 
Population stratification errors are a major problem in 
case-control studies because they can generate spurious 
positive associations [41]. The population stratification 
should be minimized in our study cohort given the 
genetic homogeneity of the Japanese population. 
However, to exclude a potential stratification in our 
study cohort, we examined the population stratification 
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performed in previous genetic association studies on 
Japanese populations [43-45]. The following 26 
polymorphic SNPs, which were randomly distributed 
along the genome and are not in LD with each other (r
2 
< 0.035), were used for this analysis: rs3818729 
(1p13.2), rs13388696 (2p23.1), rs2305619 (3q25.32), 
rs6876885 (5p15.1), rs6459193 (6p11.2), rs3779109 
(7p22.1), rs6468284 (8p12), rs955220 (9p24.3), 
rs4838590 (10q11.22), rs12806 (10q24.2), rs2019938 
(11p15.5), rs609017 (11q24.3), rs3912640 (12p13.2), 
rs2283299 (12p13.33), rs715948 (12q13.3), rs7328193 
(13q12.11), rs1048990 (14q13.2), rs16948719 
(15q22.31), rs11076720 (16q24.3), rs1051009 
(17p13.2), rs1292033 (17q23.1), rs7239116 (18q11.2), 
rs892115 (19p13.2), rs844906 (20p11.21), rs2825761 
(21q21.1), and rs3884935 (22q13.1). The log likelihood 
of each analysis at varying number of K (the number of 
populations) was estimated from three independent runs 
(20,000 burn in and 30,000 iterations). The best 
estimate of K was identified by computing posterior 
probabilities Pr (K = 1, 2, 3, 4, or 5) based on the log 
likelihood as described by Pritchard et al. [46]. 
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